Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways

Molecular mechanisms of diabetic kidney disease

(2014) Kimberly Reidy et al.   JOURNAL OF CLINICAL INVESTIGATION

Cellular and molecular mechanisms in kidney fibrosis

(2014) Jeremy S. Duffield   JOURNAL OF CLINICAL INVESTIGATION

A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers

(2014) Ron Korstanje et al.   KIDNEY INTERNATIONAL

GLUT1 Regulation of the Pro-Sclerotic Mediators of Diabetic Nephropathy

(2013) Charles W. Heilig et al.   AMERICAN JOURNAL OF NEPHROLOGY

miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes

(2013) X. Zhong et al.   DIABETOLOGIA

Molecular basis of organ fibrosis: Potential therapeutic approaches

(2013) Asish K Ghosh et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function

(2013) Laura L. Dugan et al.   JOURNAL OF CLINICAL INVESTIGATION

Association of peroxisome proliferator-activated receptors/retinoic acid receptors with renal diseases

(2013) Tian-Biao Zhou et al.   JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION

Genetic Variants in Membranous Nephropathy: Perhaps a Perfect Storm Rather than a Straightforward Conformeropathy?

(2013) D. J. Salant   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

MicroRNAs as potential therapeutic targets in kidney disease

(2013) Ivan G. Gomez et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport

(2013) Catherine K. Yeung et al.   KIDNEY INTERNATIONAL

Comprehensive molecular characterization of clear cell renal cell carcinoma

(2013)   NATURE

Molecular genetics of familial hematuric diseases

(2013) C. Deltas et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Therapy for Fibrotic Diseases: Nearing the Starting Line

(2013) S. L. Friedman et al.   Science Translational Medicine

Outcomes of Male Patients with Alport Syndrome Undergoing Renal Replacement Therapy

(2012) J. Temme et al.   Clinical Journal of the American Society of Nephrology

The role of non-coding RNAs in diabetic nephropathy: Potential applications as biomarkers for disease development and progression

(2012) M. Lucrecia Alvarez et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Alport syndrome—insights from basic and clinical research

(2012) Jenny Kruegel et al.   Nature Reviews Nephrology

MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways

(2012) B. N. Chau et al.   Science Translational Medicine

MicroRNA Circuits in Transforming Growth Factor-β Actions and Diabetic Nephropathy

(2012) Mitsuo Kato et al.   SEMINARS IN NEPHROLOGY

miR-21 and miR-214 Are Consistently Modulated during Renal Injury in Rodent Models

(2011) Laura Denby et al.   AMERICAN JOURNAL OF PATHOLOGY

Mechanisms of fibrosis: the role of the pericyte

(2011) Claudia Schrimpf et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Uncoupling proteins and the control of mitochondrial reactive oxygen species production

(2011) Ryan J. Mailloux et al.   FREE RADICAL BIOLOGY AND MEDICINE

Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice

(2011) Nariaki Asada et al.   JOURNAL OF CLINICAL INVESTIGATION

mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice

(2011) Ken Inoki et al.   JOURNAL OF CLINICAL INVESTIGATION

Tumour necrosis factor-α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis

(2011) Mi Ryu et al.   JOURNAL OF PATHOLOGY

Indoxyl Sulfate Induces Nephrovascular Senescence

(2011) Toshimitsu Niwa et al.   JOURNAL OF RENAL NUTRITION

The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats

(2011) Peter Boor et al.   KIDNEY INTERNATIONAL

Oxidative Stress in Diabetic Nephropathy

(2010) N. Kashihara et al.   CURRENT MEDICINAL CHEMISTRY

Identification of a microRNA signature of renal ischemia reperfusion injury

(2010) J. G. Godwin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis

(2009) Benjamin D. Humphreys et al.   AMERICAN JOURNAL OF PATHOLOGY

The Renal Lesions of Alport Syndrome

(2009) L. Heidet et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Multiple loci associated with indices of renal function and chronic kidney disease

(2009) Anna Köttgen et al.   NATURE GENETICS

Prevalence of CKD in the United States: A Sensitivity Analysis Using the National Health and Nutrition Examination Survey (NHANES) 1999-2004

(2008) Jon J. Snyder et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

(2008) Thomas Thum et al.   NATURE

Potent inhibition of microRNA in vivo without degradation

(2008) Scott Davis et al.   NUCLEIC ACIDS RESEARCH

Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease

(2008) S. Krick et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Emerging Roles of Peroxisome Proliferator-Activated Receptors (PPARs) in the Regulation of Neural Stem Cells Proliferation and Differentiation

(2008) AnnaMaria Cimini et al.   Stem Cell Reviews and Reports